
Guidance on Submitting Standardized Study Data
FDA published guidance for submitting standardized study data in electronic format.
FDA issued
The guidance discusses the requirements for electronic submission of study data including exchange format standards, study data standards, and controlled terminology standards. It also discusses the agency’s policy on waivers of electronic submission requirements.
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.